Humoral and cellular immune responses to measles and tetanus: The importance of elapsed time since last exposure and the nature of the antigen

Journal of Clinical Immunology

Volumn 30, Issue 4, 2010, Pages 574-582

  Viana, Patricia O ^a   Ono, Erika ^a   Miyamoto, Maristela ^a   Salomao, Reinaldo ^a   Costa Carvalho, Beatriz T ^a   Weckx, Lily Y ^a   De Moraes Pinto, Maria Isabel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibody; Cellular immunity; Immunologic memory; Measles; Tetanus

Indexed keywords

DIPHTHERIA TETANUS TOXOID; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; ANTIBODY; ANTIGEN; MEASLES VACCINE;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IN VITRO STUDY; INTERFERON PRODUCTION; MEASLES; NORMAL HUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; TETANUS; TETANUS PROPHYLAXIS; THERAPY DELAY; VACCINATION; BLOOD; CLINICAL TRIAL; FEMALE; IMMUNIZATION; IMMUNOLOGY; MALE; MIDDLE AGED; PROCEDURES; TIME; YOUNG ADULT;

ADULT; ANTIBODIES; ANTIGENS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION, SECONDARY; MALE; MEASLES; MEASLES VACCINE; MIDDLE AGED; TETANUS; TETANUS TOXOID; TIME FACTORS; YOUNG ADULT;

EID: 77956263905     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9420-7     Document Type: Article

References (26)

1. Plotkin SA. Vaccines: past, present and future. Nat Med. 2005;11(4):S5-11.
2. Kaufmann S H E. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol. 2007;5(7):491-504.
3. Maino VC, Maecker HT. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens. Clin Immunol. 2004;110:222-31.
4. World Health Organization (WHO): Measles imported cases in Santa Catarina, Brazil. EID Weekly Updates: emerging and reemerging infection diseases, Region of the Americas. http://www.paho.org/English/AD/DPC/CD/eid-eer- 24-dec-2003.htm. Accessed 28 Sep. 2009.
5. Borrow R, Balmer P, Roper MH. The immunological basis for immunization series. Module 3: tetanus. Geneva: World Health Organization; 2006. p. 1-52.
6. Gaines H, Biberfeld G. Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol Biol. 2000;134:243-55.
7. Pala P, Hussell T, Openshaw P J M. Flow cytometric measurement of intracellular cytokines. J Immunol Methods. 2000;243:107-24.
8. Kristiansen M, Aggerbeck H, Heron I. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. Acta Pathol Microbiol Scand. 1997;105:843-53.
9. de Moraes-Pinto MI, Almeida A C M, Kenj G, Filgueiras TE, Tobias W, Santos A M N, et al. Placental transfer and maternally acquired neonatal Igg immunity in HIV infection. J Infect Dis. 1996;173:1077-84.
10. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036-42.
11. Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356(11):1121-9.
12. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008;197:1419-26.
13. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 2008;28(5):710-22.
14. Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery CM, Silvestri G, et al. Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods. 2003;278:145-55.
15. Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods. 1998;212:89-98.
16. Nanan R, Rauch A, Kämpgen E, Niewiesk S, Kreth HW. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol. 2000;81:1313-9.
17. + T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol. 2003;10(3):411-6.
18. Christenson B, Bottinger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 1994;12(2):129-33.
19. Caglar K, Karakus R, Aybay C. Determination of tetanus antibodies by double-antigen enzyme-linked immunosorbent assay in individuals of various age groups. Eur J Clin Microbiol Infect Dis. 2005;24:523-8.
20. Lambert PH, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med. 2005;11(4):S54-62.
21. Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol. 1999;150:1238-49.
22. LeBaron CW, Beeler J, Bradley J, Sullivan BJ, Forghani B, Bi D, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;161:294-301.
23. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197(7):950-6.
24. Putz MM, Bouche FB, Swart RL, Muller CP. Experimental vaccines against measles in a world of changing epidemiology. Int J Parasitol. 2003;33:525-45.
25. Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A. Humoral immunity and long-lived plasma cells. Curr Opin Immunol. 2002;14(4):517-21.
26. Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol. 1998;10(3):252-8.